Psomagen Statistics
Total Valuation
Psomagen has a market cap or net worth of KRW 75.98 billion. The enterprise value is 75.41 billion.
Market Cap | 75.98B |
Enterprise Value | 75.41B |
Important Dates
The last earnings date was Thursday, May 15, 2025.
Earnings Date | May 15, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Psomagen has 19.24 million shares outstanding. The number of shares has increased by 3.32% in one year.
Current Share Class | n/a |
Shares Outstanding | 19.24M |
Shares Change (YoY) | +3.32% |
Shares Change (QoQ) | -11.97% |
Owned by Insiders (%) | 2.34% |
Owned by Institutions (%) | n/a |
Float | 8.25M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 1.67 |
PB Ratio | 2.68 |
P/TBV Ratio | 3.42 |
P/FCF Ratio | 64.41 |
P/OCF Ratio | 15.14 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 264.37, with an EV/FCF ratio of 63.92.
EV / Earnings | -13.36 |
EV / Sales | 1.65 |
EV / EBITDA | 264.37 |
EV / EBIT | n/a |
EV / FCF | 63.92 |
Financial Position
The company has a current ratio of 1.46, with a Debt / Equity ratio of 0.50.
Current Ratio | 1.46 |
Quick Ratio | 1.04 |
Debt / Equity | 0.50 |
Debt / EBITDA | 35.70 |
Debt / FCF | 12.10 |
Interest Coverage | -9.81 |
Financial Efficiency
Return on equity (ROE) is -21.04% and return on invested capital (ROIC) is -7.78%.
Return on Equity (ROE) | -21.04% |
Return on Assets (ROA) | -6.12% |
Return on Invested Capital (ROIC) | -7.78% |
Return on Capital Employed (ROCE) | -12.98% |
Revenue Per Employee | 465.53M |
Profits Per Employee | -57.61M |
Employee Count | 89 |
Asset Turnover | 0.90 |
Inventory Turnover | 7.12 |
Taxes
In the past 12 months, Psomagen has paid 8.74 million in taxes.
Income Tax | 8.74M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -12.95% in the last 52 weeks. The beta is 0.15, so Psomagen's price volatility has been lower than the market average.
Beta (5Y) | 0.15 |
52-Week Price Change | -12.95% |
50-Day Moving Average | 3,605.00 |
200-Day Moving Average | 4,075.70 |
Relative Strength Index (RSI) | 57.86 |
Average Volume (20 Days) | 96,587 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Psomagen had revenue of KRW 45.62 billion and -5.65 billion in losses. Loss per share was -287.53.
Revenue | 45.62B |
Gross Profit | 10.06B |
Operating Income | -4.95B |
Pretax Income | -6.33B |
Net Income | -5.65B |
EBITDA | 400.00M |
EBIT | -4.95B |
Loss Per Share | -287.53 |
Balance Sheet
The company has 14.15 billion in cash and 14.28 billion in debt, giving a net cash position of -133.06 million or -6.92 per share.
Cash & Cash Equivalents | 14.15B |
Total Debt | 14.28B |
Net Cash | -133.06M |
Net Cash Per Share | -6.92 |
Equity (Book Value) | 28.32B |
Book Value Per Share | 1,441.21 |
Working Capital | 8.55B |
Cash Flow
In the last 12 months, operating cash flow was 5.02 billion and capital expenditures -3.84 billion, giving a free cash flow of 1.18 billion.
Operating Cash Flow | 5.02B |
Capital Expenditures | -3.84B |
Free Cash Flow | 1.18B |
FCF Per Share | 61.33 |
Margins
Gross margin is 22.05%, with operating and profit margins of -10.84% and -12.38%.
Gross Margin | 22.05% |
Operating Margin | -10.84% |
Pretax Margin | -13.87% |
Profit Margin | -12.38% |
EBITDA Margin | 0.88% |
EBIT Margin | -10.84% |
FCF Margin | 2.59% |
Dividends & Yields
Psomagen does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -3.32% |
Shareholder Yield | n/a |
Earnings Yield | -7.43% |
FCF Yield | 1.55% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Psomagen has an Altman Z-Score of 0.24 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 0.24 |
Piotroski F-Score | 3 |